Hepatic drug monitoring in patients exposed to antitubercular treatment
Domínguez, J.P.; Amenábar, E.; Mendoza, F.; Pivet, H.; Palacios, L.; Lagos, A.; Diaz, N.; Calderón, J.; Cardenas, R.; Pérez-Olea, J.
Revista Medica de Chile 110(8): 733-737
1982
ISSN/ISBN: 0034-9887 PMID: 7156604 Document Number: 188365
Document emailed within 1 workday
Related Documents
Daix, T.; Domoua, K.; Coulibaly, G.; Kissi, H.; Beugre-Sy, L.; Yapi, A. 2003: Antitubercular drug treatment failure and HIV infection in Abidjan (Ivory Coast) Bulletin de la Societe de Pathologie Exotique 96(1): 39-40Grover, S.K.; Srivastava, K.K.; Singh, V.S.; Misra, U.K. 1985: Effect of vitamin A on hepatic microsomal drug metabolising enzymes activity in rats exposed to acute hypoxia International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 55(4): 391-393
Bruzzone, M.; Calabresi, C.; Figari, G.; Piccardo, M.; Baldini, I.; Cacciabue, E.; Gollo, E. 1982: Studies of welders exposed to zinc fumes. Environmental prevention, indications for biological monitoring of exposed workers La Medicina del Lavoro 73(6): 619-627
Dautzenberg, B.; Gallinari, C.; Aeberhardt, G.; Lévy, A.; Bernheim, J.; Grosset, J.; Sors, C. 1986: Routine use of 6-month antitubercular treatment in 300 patients Presse Medicale 15(43): 2151
Mikhaĭlova, E.S.; Vilenskaia, R.N.; Kanevskaia, S.S. 1974: Intravenous administration of antitubercular preparations in the complex treatment of patients with pulmonary tuberculosis associated with peptic ulcer Terapevticheskii Arkhiv 46(5): 129-133
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Saigal, S.; Agarwal, S.R.; Nandeesh, H.P.; Sarin, S.K. 2001: Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: A preliminary report Journal of Gastroenterology and Hepatology 16(9): 1028-1032
Farrell, G.C.; Cooksley, W.G.; Hart, P.; Powell, L.W. 1978: Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism Gastroenterology 75(4): 580-588
Tebit, D.M.; Sangaré, L.; Makamtse, A.; Yameogo, S.; Somlare, H.; Bado, G.; Kouldiaty, B.G.; Sathiandee, K.; Tiba, F.; Sanou, I.; Ouédraogo-Traoré, R.; Zoungrana, L.é; Diallo, I.; Drabo, J.Y.; Kräusslich, H.-G. 2008: HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina Faso Journal of Acquired Immune Deficiency Syndromes 49(1): 17-25
Rock, R.C. 1985: Monitoring therapeutic drug levels in older patients Geriatrics 40(6): 75
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Khomenko, A.G.; Shmelev, N.A.; Stepanian, E.S.; Priss, I.S.; Koviazina, A.I. 1976: Side effects of antitubercular agents and current methods of detection of drug allergy in chemotherapy of tuberculosis Problemy Tuberkuleza 3: 18-24
Miller, R.; Nowosiad, D.; Warnes, D.M.; De Wet, J.M. 1982: The role of therapeutic drug monitoring in the care of epileptic patients South African Medical Journal 62(15): 512-515
Winkler, M.; Ringe, B.; Baumann, J.; Loss, M.; Wonigeit, K.; Pichlmayr, R. 1994: Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression Clinical Chemistry 40(12): 2247-2253
Ohgitani, S.; Funaki, M.; Tanaka, K.; Hatsuda, K.; Ito, K.; Kushiro, H.; Izumi, S.; Kishimoto, Y.; Kodama, J. 1984: Therapeutic drug monitoring in the postoperative digitalization for patients with open heart surgery Rinsho Byori. Japanese Journal of Clinical Pathology 32(2): 173-176
Waisser, K.; Celadník, M.; Sova, J.; Palát, K. 1975: Antitubercular agents. XVI. use of HMO computations in the study of structure-activity relationship of antitubercular agents. IIi Ceskoslovenska Farmacie 24(10): 423-426
Horne, H.W.; Kundsin, R.B. 1985: Results of infertility studies on 1001 DES-exposed and non DES-exposed consecutive patients International Journal of Fertility 30(1): 46-49
Deng, C.-H.; Zhang, G.-M.; Bi, S.-S.; Zhou, T.-Y.; Lu, W. 2011: The therapeutic drug monitoring network server of tacrolimus for Chinese renal transplant patients Yao Xue Xue Bao 46(7): 828-833
Ciorciaro, C.; Hartmann, K.; Stoller, R.; Kuhn, M. 1996: Liver injury caused by coumarin anticoagulants: experience of the IKS (Intercanton Monitoring Station) and the SANZ (Swiss Center for Drug Monitoring) Schweizerische Medizinische Wochenschrift 126(49): 2109-2113
Lertpiriyasuwat, C.; Teeraratkul, A.; Suchonwanich, Y.; Chatharojwong, N.; Phokasawad, K.; Yuktanon, P.; Pattarapayoon, N.; Bhakeecheep, S.; Bertagnolio, S.; Roels, T.H.; Thanprasertsuk, S. 2017: Monitoring HIV Drug Resistance: Early Warning Indicators to Assess Performance of Thailand's Antiretroviral Treatment Program Journal of the Medical Association of Thailand 100(9): 944-952